In conclusion, this study indicates that KIT mutations are the key risk factors for the prognosis of t(8,21) AML but not inv(16) AML, thereby supporting the inclusion of testing for KIT mutational status in the initial routine diagnostic workup and stratification system of t(8,21) AML. The gene discussed is KIT; the disease is acute myeloid leukemia.